Complement interaction with trypanosomatid promastigotes in normal human serum.
about
Innate immunity against Leishmania infectionsInefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cellsGeographical distribution of complement receptor type 1 variants and their associated disease risk.Distinct cellular migration induced by Leishmania infantum chagasi and saliva from Lutzomyia longipalpis in a hemorrhagic pool model.Kinetic analysis of ex vivo human blood infection by Leishmania.Deception and manipulation: the arms of leishmania, a successful parasiteThe levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculumDifferent host complement systems and their interactions with saliva from Lutzomyia longipalpis (Diptera, Psychodidae) and Leishmania infantum promastigotes.Serum Removal from Culture Induces Growth Arrest, Ploidy Alteration, Decrease in Infectivity and Differential Expression of Crucial Genes in Leishmania infantum Promastigotes.Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes.Vaccine Development Against Leishmania donovani.The Sand Fly Salivary Protein Lufaxin Inhibits the Early Steps of the Alternative Pathway of Complement by Direct Binding to the Proconvertase C3b-B.Comment on "Regulation of immunity during visceral Leishmania infection" and further discussions about the role of antibodies in infections with Leishmania.The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice.Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease.An evolutionary analysis of trypanosomatid GP63 proteases.The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.
P2860
Q27010187-E7D85F56-A3BB-4E94-8C78-0E01BB16C951Q33543089-A040C358-5737-46A5-BDC9-F82CC0A9449EQ33698822-B0928A2E-C1E4-4C6B-BB4F-2A9F08F29F92Q33859594-8013FABA-6E8B-41DD-824F-009F182FB4D2Q33991563-EB7E002E-8235-47BB-A3CC-2EDDCEAE02FEQ34369161-9D25B679-F97B-4E8A-B4D4-2D7A5DA6C4C8Q34932397-58ACFCD6-3676-4B76-B0A3-0C97EBDA3FD0Q35047441-151F1ED9-46E0-45AE-AE0B-F23BC692C058Q35951052-31FD2574-0925-40EB-893D-B792B9CA54C4Q36778915-35B58548-C5E6-4804-B283-C17E9FA6B519Q38012112-CBFA58B1-EE24-4FA7-8147-0D3A66AB360FQ40044852-2756E3EF-F8E6-4B3A-BC81-040FBE7C858AQ42429227-C25A2A32-1A78-4083-89B2-77797071996AQ47831266-CC5E6ED2-07F2-436D-8AD7-1D2211F4820FQ48262765-ECFF8922-EABB-45D2-AC0F-93AB573211CBQ52718974-10F7F81C-1F28-4948-813F-F39906452314Q55686634-F809BCC9-624D-48F2-8098-239A9144C3E4
P2860
Complement interaction with trypanosomatid promastigotes in normal human serum.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Complement interaction with trypanosomatid promastigotes in normal human serum.
@en
type
label
Complement interaction with trypanosomatid promastigotes in normal human serum.
@en
prefLabel
Complement interaction with trypanosomatid promastigotes in normal human serum.
@en
P2093
P2860
P356
P1476
Complement interaction with trypanosomatid promastigotes in normal human serum.
@en
P2093
Alfredo Toraño
Inmaculada Moreno
Margarita López-Trascasa
Mercedes Domínguez
P2860
P304
P356
10.1084/JEM.20011319
P407
P577
2002-02-01T00:00:00Z